Correlation Between AN2 Therapeutics and Dyne Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Dyne Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Dyne Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Dyne Therapeutics, you can compare the effects of market volatilities on AN2 Therapeutics and Dyne Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Dyne Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Dyne Therapeutics.

Diversification Opportunities for AN2 Therapeutics and Dyne Therapeutics

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between AN2 and Dyne is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Dyne Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dyne Therapeutics and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Dyne Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dyne Therapeutics has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Dyne Therapeutics go up and down completely randomly.

Pair Corralation between AN2 Therapeutics and Dyne Therapeutics

Given the investment horizon of 90 days AN2 Therapeutics is expected to generate 0.53 times more return on investment than Dyne Therapeutics. However, AN2 Therapeutics is 1.88 times less risky than Dyne Therapeutics. It trades about -0.1 of its potential returns per unit of risk. Dyne Therapeutics is currently generating about -0.39 per unit of risk. If you would invest  135.00  in AN2 Therapeutics on January 8, 2025 and sell it today you would lose (10.00) from holding AN2 Therapeutics or give up 7.41% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

AN2 Therapeutics  vs.  Dyne Therapeutics

 Performance 
       Timeline  
AN2 Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days AN2 Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, AN2 Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Dyne Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Dyne Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in May 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

AN2 Therapeutics and Dyne Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AN2 Therapeutics and Dyne Therapeutics

The main advantage of trading using opposite AN2 Therapeutics and Dyne Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Dyne Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyne Therapeutics will offset losses from the drop in Dyne Therapeutics' long position.
The idea behind AN2 Therapeutics and Dyne Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.